UniSa - IRIS Institutional Research Information System

RAIMONDO, ANNUNZIATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.913
AS - Asia 3.106
EU - Europa 3.066
SA - Sud America 347
AF - Africa 50
OC - Oceania 4
AN - Antartide 1
Totale 11.487
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.846
HK - Hong Kong 1.473
IT - Italia 1.206
FI - Finlandia 1.199
SG - Singapore 792
CN - Cina 321
BR - Brasile 247
VN - Vietnam 192
RU - Federazione Russa 150
FR - Francia 93
DE - Germania 89
IN - India 73
IE - Irlanda 64
KR - Corea 61
NL - Olanda 51
SE - Svezia 48
AR - Argentina 47
GB - Regno Unito 42
JP - Giappone 35
CA - Canada 32
BD - Bangladesh 29
PL - Polonia 20
MX - Messico 19
AT - Austria 18
ES - Italia 17
UA - Ucraina 17
EC - Ecuador 16
TR - Turchia 16
PK - Pakistan 15
CO - Colombia 14
IQ - Iraq 14
CH - Svizzera 13
ID - Indonesia 13
ZA - Sudafrica 10
EG - Egitto 9
HR - Croazia 9
PH - Filippine 9
TN - Tunisia 7
UZ - Uzbekistan 7
VE - Venezuela 7
JO - Giordania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
LT - Lituania 5
MY - Malesia 5
OM - Oman 5
SA - Arabia Saudita 5
AU - Australia 4
CZ - Repubblica Ceca 4
PE - Perù 4
PY - Paraguay 4
BE - Belgio 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IR - Iran 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
BH - Bahrain 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
NI - Nicaragua 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MU - Mauritius 1
NE - Niger 1
NO - Norvegia 1
PA - Panama 1
Totale 11.481
Salva come PNG Salva come JPEG
Città #
Dallas 2.839
Hong Kong 1.469
Helsinki 1.182
San Jose 449
Singapore 377
Chandler 231
Princeton 149
Ashburn 146
Rome 123
Milan 106
Council Bluffs 91
Beijing 75
The Dalles 73
Ho Chi Minh City 70
Lauterbourg 70
Naples 69
Moscow 63
Dublin 62
Ann Arbor 52
New York 48
Los Angeles 43
Munich 43
Salerno 36
Tokyo 34
Wilmington 34
Hanoi 31
São Paulo 28
Santa Clara 27
Amsterdam 26
Bari 24
Genoa 24
Seattle 23
Houston 21
Stockholm 21
Palermo 18
Andover 17
Chennai 17
Warsaw 17
London 16
Nuremberg 16
Turin 16
Bologna 15
Jacksonville 15
Denver 14
Dong Ket 14
Fisciano 14
Montreal 14
Orem 14
Seoul 14
Brooklyn 13
Columbus 13
Florence 13
Boston 12
Mumbai 12
Turku 12
Verona 12
Woodbridge 12
Frankfurt am Main 11
Boardman 10
Cava de' Tirreni 10
Da Nang 9
Pune 9
Albignasego 8
Atlanta 8
Catania 8
Padova 8
West Jordan 8
Belo Horizonte 7
Charlotte 7
Cinisello Balsamo 7
Guangzhou 7
Phoenix 7
Rio de Janeiro 7
Sarno 7
Thái Nguyên 7
Venice 7
Asti 6
Baghdad 6
Buenos Aires 6
Haiphong 6
Jakarta 6
Lahore 6
Lamezia Terme 6
Messina 6
Mexico City 6
Napoli 6
Poplar 6
Quito 6
Rimini 6
San Francisco 6
Acerra 5
Addis Ababa 5
Brasília 5
Campinas 5
Domicella 5
Istanbul 5
Izmir 5
Lappeenranta 5
Manchester 5
Marcianise 5
Totale 8.775
Salva come PNG Salva come JPEG
Nome #
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 3.979
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 817
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 476
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 439
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 237
Psoriasi eritrodermica: rapida efficacia di bimekizumab 205
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 147
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 141
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 131
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 129
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection 129
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 126
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 118
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 116
Atopic dermatitis: Epidemiology and clinical phenotypes 111
Presence of BAG3 protein in serum samples from patients affected by psoriasis 105
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 101
Interleukin-33: increasing role in dermatological conditions 98
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 98
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 92
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 92
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 89
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 83
Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review 82
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 82
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 80
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 80
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 79
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 78
IL-33 is regulated by TNF-α in normal and psoriatic skin 78
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 78
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 76
The laboratory role in the assessment of sensitization and irritation potential of cosmetics 75
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 74
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 73
A journey into psoriasis: From the adipose tissue to the skin 72
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 70
RAST: Clinical applications 70
Guselkumab for the treatment of psoriasis 70
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions 69
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 68
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 68
Clinical predictors of psoriatic arthritis and osteoclast differentiation 68
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 66
A potential prognostic test for bone erosion development in patients with cutaneous predictive sites for psoriatic arthritis 66
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 65
IL-26 in allergic contact dermatitis: Resource in a state of readiness 65
The role of the dermatologist in the immune-mediated/allergic diseases – position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum 62
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 62
Psoriasis, cardiovascular events, and biologics: Lights and shadows 61
Flash-pumped pulsed dye laser for vascular skin lesions: our experience and an overview of the literature 61
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 59
Photosensitivity and cancer immune-targeted therapies 59
Human Microbiome: Composition and Role in Inflammatory Skin Diseases 58
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 58
Polymorphic light eruption: What's new in pathogenesis and management 57
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 55
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 54
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 53
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 50
The effects of skin psoriasis inflammation on adipose tissue-derived mediators and viceversa 50
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 50
IL-26: A new actor in allergic contact dermatitis 49
UVB-induced p53 is reduced by a mixture of natural extracts 49
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 48
Guselkumab e psoriasi in sedi difficili: efficacia ed impatto sulla qualità di vita in pazienti naive o bio experienced 47
Ultrasonography in the management of a recurrent and eruptive lobular capillary hemangioma and resolution with intense pulsed light 46
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 46
New insights into mechanism of Notch signaling in hidradenitis suppurativa 44
Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: A cross-sectional study in Italy 44
Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study 43
Photodermatoses and Skin Cancer 42
Studio osservazionale descrittivo per la valutazione della prevalenza della psoriasi nei pazienti adulti dislipidemici in terapia monoclonale con anti-PCSK9 41
Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb 41
Systemic inflammation: psoriasis as a model…in Naples 41
Novel interactions among ultraviolet B, skin and adipose tissue 40
Oxidative Stress in Atopic Dermatitis and Possible Biomarkers: Present and Future 39
Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future 38
Psoriasi e terapia con guselkumab: panoramica 2022 dal centro prescrittore AOU Salerno 36
Letters to the editor 36
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study 35
Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy 33
Dermatite atopica e stress ossidativo: nuovi biomarker 32
Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series 31
The role of the RNA-binding protein AUF-1 in chronic inflammatory skin diseases and cellular senescence 28
Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study 5
Totale 11.594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022255 2 4 3 20 30 2 0 11 21 5 40 117
2022/2023544 55 56 27 74 27 102 6 53 87 15 27 15
2023/2024541 23 54 39 26 35 45 28 46 18 66 54 107
2024/20251.533 65 36 115 137 79 187 169 86 240 88 145 186
2025/20268.527 252 1.644 2.755 316 478 243 648 144 1.389 463 162 33
Totale 11.594